Strategic Collaboration Cognigen operates as a division of Simulations Plus focused on model-based drug development with a strong emphasis on PK/PD modeling, clinical trial simulations, and exposure-response analyses, making them a compelling partner for pharma companies pursuing regulatory-enabled decision support and high-quality technical reporting.

Regulatory Enablement Their services are designed to deliver comprehensive technical reports and analysis findings to support knowledge-based decisions at critical regulatory milestones, suggesting opportunities to position expanded regulatory submission support and regulatory strategy services.

Tech-Enabled Delivery Leveraging PERSPECTIVE Hypertext Data Analysis Mapping software, real-time collaboration, and cloud infrastructure (AWS, GitHub Actions) indicates a readiness to scale bespoke modeling work with efficient project collaboration, ideal for global teams and complex CRO partnerships.

Growth Signals With a mid-market footprint (11-50 employees) and revenue in a broad range, plus recent favorable news and potential acquisition activity, there is an opening for complementary analytics, data management, or AI-augmented modeling tools to accelerate project timelines and expand capacity.

AI and GPU Momentum Existing partnerships and news around NVIDIA collaboration point to an interest in accelerated modeling workflows; this suggests upsell opportunities in GPU-accelerated computing, AI-driven pharmacometrics, and scalable cloud-based analytics solutions.